ID
11614
Descripción
CALGB: 40101 PRE-STUDY ELIGIBILITY CHECKLIST NCT00041119 Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A4CFBF75-6AD3-69D3-E034-080020C9C0E0
Link
Palabras clave
Versiones (3)
- 26/8/12 26/8/12 -
- 8/7/15 8/7/15 -
- 8/7/15 8/7/15 -
Subido en
8 de julio de 2015
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
CALGB: 40101 PRE-STUDY ELIGIBILITY CHECKLIST NCT00041119
INSTRUCTIONS: Complete all information on this form. Do not leave any entries blank.
- StudyEvent: CALGB: 40101 PRE-STUDY ELIGIBILITY CHECKLIST
Descripción
Breast Cancer ELIGIBILITY
Descripción
Histologically confirmed invasive carcinoma of the breast
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0853879
Descripción
Undergone either modified radical mastectomy or lumpectomy
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0024884
- UMLS CUI-2
- C0740370
Descripción
Negative tumor margins for invasive cancer and DCIS in case of mastectomy or lumpectomy
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0332648
Descripción
No locally advanced breast cancer, inflammatory breast cancer or metastatic breast cancer
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0006142
- UMLS CUI-2
- C0278601
- UMLS CUI-3
- C0278488
Descripción
No involvement of dermal lymphatics on pathology
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0024235
- UMLS CUI-2
- C0221928
- UMLS CUI-3
- C1314939
Descripción
"High-risk" node-negative breast cancer (guidelines are ER/PgR positive primary tumor >= 1 cm in greatest diameter, or ER/PgR negative tumor of any size; physician discretion is allowed)
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0006142
- UMLS CUI-2
- C0332167
- UMLS CUI-3
- C2371027
Descripción
Negative sentinel node biopsy, and/or an axillary dissection where at least 6 lymph nodes are removed and found to be negative
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0796693
- UMLS CUI-2
- C0193867
Descripción
<= 84 days since last major breast surgery
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0851312
- UMLS CUI-2
- C3646033
Descripción
No previous chemotherapy or hormonal therapy (except for tamoxifen as described in the protocol) for this malignancy
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C3665472
- UMLS CUI-2
- C0279025
Descripción
Age >= 18 years
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0001779
Descripción
CTC Performance status 0-1
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0027625
- UMLS CUI-2
- C1518965
Descripción
Non-pregnant and non-nursing
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0232973
- UMLS CUI-2
- C0006147
Descripción
No active congestive heart failure nor myocardial infarction within 6 months prior to registration
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0018802
- UMLS CUI-2
- C0027051
Descripción
Disease-free of prior invasive malignancies for >5 years except for curatively treated basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0242793
- UMLS CUI-2
- C0677898
Descripción
Willing to stop exogenous hormone therapy, including oral contraceptives, post-menopausal hormone replacement therapy, and raloxifene
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0600109
- UMLS CUI-2
- C1516999
- UMLS CUI-3
- C2746065
Descripción
Discontinued tamoxifen at time of enrollment to study if tamoxifen has been received as breast cancer preventive agent, or as treatment for this malignancy for <= 4 weeks. (If latter, indicate dates below)
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0039286
- UMLS CUI-2
- C1444662
Descripción
Date tamoxifen started
Tipo de datos
date
Alias
- NCI Thesaurus ValueDomain
- C25164
- UMLS CUI-1
- C3173309
- UMLS CUI-2
- C0039286
Descripción
Date tamoxifen discontinued
Tipo de datos
date
Alias
- NCI Thesaurus ValueDomain
- C25164
- UMLS CUI-1
- C0039286
- UMLS CUI-2
- C2826748
Descripción
Meets ALL of the following laboratory criteria completed within 16 days before registration
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0022877
- UMLS CUI-2
- C0243161
Descripción
ANC >= 1000/mcL
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0948762
- UMLS CUI-2
- C0439378
Descripción
Date obtained (ANC)
Tipo de datos
date
Alias
- NCI Thesaurus ValueDomain
- C25164
- UMLS CUI-1
- C0948762
- UMLS CUI-2
- C1277697
Descripción
Platelets >= 100,000/mcL
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0032181
- UMLS CUI-2
- C0439378
Descripción
Date obtained (Platelets)
Tipo de datos
date
Alias
- NCI Thesaurus ValueDomain
- C25164
- UMLS CUI-1
- C1277697
- UMLS CUI-2
- C0032181
Descripción
Creatinine <= 2.0 mg/dL
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0201975
- UMLS CUI-2
- C0439269
Descripción
Date obtained (Creatinine)
Tipo de datos
date
Alias
- NCI Thesaurus ValueDomain
- C25164
- UMLS CUI-1
- C1277697
- UMLS CUI-2
- C0201975
Descripción
Total Bilirubin < 1.5 x upper limits of normal of laboratory (mg/dL)
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0201913
- UMLS CUI-2
- C0439269
Descripción
Date obtained (Total Bilirubin)
Tipo de datos
date
Alias
- NCI Thesaurus ValueDomain
- C25164
- UMLS CUI-1
- C1277697
- UMLS CUI-2
- C0201913
Descripción
ULN (Total Bilirubin)
Tipo de datos
integer
Alias
- UMLS CUI-1
- C1519815
- UMLS CUI-2
- C0201913
Descripción
Ccrr Module For Calgb: 40101 Pre-study Eligibility Checklist
Similar models
INSTRUCTIONS: Complete all information on this form. Do not leave any entries blank.
- StudyEvent: CALGB: 40101 PRE-STUDY ELIGIBILITY CHECKLIST
C2603343 (UMLS CUI-2)
C0030692 (UMLS CUI-2)
C1257890 (UMLS 2011AA ObjectClass)
C25364 (NCI Thesaurus Property)
C0600091 (UMLS 2011AA Property)
C0237753 (UMLS CUI-2)
C2607850 (UMLS CUI-2)
C0600091 (UMLS CUI-2)
C0740370 (UMLS CUI-2)
C0278601 (UMLS CUI-2)
C0278488 (UMLS CUI-3)
C0221928 (UMLS CUI-2)
C1314939 (UMLS CUI-3)
C0332167 (UMLS CUI-2)
C2371027 (UMLS CUI-3)
C0193867 (UMLS CUI-2)
C3646033 (UMLS CUI-2)
C0279025 (UMLS CUI-2)
C1518965 (UMLS CUI-2)
C0006147 (UMLS CUI-2)
C0027051 (UMLS CUI-2)
C0677898 (UMLS CUI-2)
C1516999 (UMLS CUI-2)
C2746065 (UMLS CUI-3)
C1444662 (UMLS CUI-2)
C3173309 (UMLS CUI-1)
C0039286 (UMLS CUI-2)
C0039286 (UMLS CUI-1)
C2826748 (UMLS CUI-2)
C0243161 (UMLS CUI-2)
C0439378 (UMLS CUI-2)
C0948762 (UMLS CUI-1)
C1277697 (UMLS CUI-2)
C0439378 (UMLS CUI-2)
C1277697 (UMLS CUI-1)
C0032181 (UMLS CUI-2)
C0439269 (UMLS CUI-2)
C1277697 (UMLS CUI-1)
C0201975 (UMLS CUI-2)
C0439269 (UMLS CUI-2)
C1277697 (UMLS CUI-1)
C0201913 (UMLS CUI-2)
C0201913 (UMLS CUI-2)